Portal:Viruses


The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as organisms at the edge of life.

Selected disease

Light microscope image of an H&E-stained liver biopsy, showing "ground glass hepatocytes" associated with chronic hepatitis B infection
Light microscope image of an H&E-stained liver biopsy, showing "ground glass hepatocytes" associated with chronic hepatitis B infection

Hepatitis B is an infectious inflammatory disease of the liver caused by the hepatitis B virus (HBV), a hepadnavirus. It affects humans and possibly other great apes. The virus is transmitted by exposure to infectious blood or some body fluids. Mother-to-child transmission is a major route in endemic countries. HBV is 50–100 times more infectious than HIV. The virus replicates in liver cells, and enters the blood where viral proteins and antiviral antibodies are found.

Acute infection is often asymptomatic but can cause liver inflammation resulting in vomiting, jaundice and, rarely, death. Over 95% of infected adults and older children clear the infection spontaneously, developing protective immunity. Only 30% of children aged 1–6 years and 5% of newborns infected perinatally clear the infection. Chronic hepatitis B may eventually progress to cirrhosis and liver cancer, causing death in around 40% of those chronically infected. The virus has infected humans since at least the Bronze Age, with HBV DNA being found in 4,500-year-old human remains. About a third of the global population has been infected at one point in their lives, including nearly 350 million who are chronic carriers. The virus is endemic in East Asia and sub-Saharan Africa. Infection can be prevented by vaccination.

Selected image

False-coloured scanning electron micrograph of SARS-CoV-2 emerging from cells in culture

False-coloured scanning electron micrograph of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; gold) emerging from cells in culture. SARS-CoV-2 is a novel coronavirus first identified in China in January 2020 as the cause of an acute respiratory disease now known as COVID-19. Cases of the disease increased rapidly and spread globally, with the World Health Organization characterising COVID-19 as a pandemic in March 2020.

Credit: National Institute of Allergy and Infectious Diseases (19 February 2020)

In the news

Selected article

Plaque assay for herpes simplex virus

Virus quantification is necessary for viral vaccine production, and is used to manage people infected with HIV, hepatitis B and C, and cytomegalovirus. A wide range of traditional and modern methods are used. Plaque assays (pictured) infect a monolayer of host cells with dilutions of the virus and count the number of holes or plaques, where cells have lysed and infected their neighbours. For viruses that do not lyse their host cell, plaques of cells showing cytopathic effects can be counted or viral proteins can be immunostained with fluorescent-labelled antibodies. These methods quantify infectious virus, while others, such as electron microscopy, return a higher concentration because they count all virus particles, whether or not they are viable. Other assays, such as the haemagglutinin assay, quantify viral proteins.

Often slow and labour intensive, traditional methods have been complemented by modern technologies that greatly reduce quantification time, including quantitative polymerase chain reaction, flow cytometry, enzyme-linked immunosorbent assays and tunable resistive pulse sensing.

Selected outbreak

Map showing Ebola virus disease cases in Guinea, Liberia and Sierra Leone in December 2014

The West African Ebola epidemic was the most widespread outbreak of the disease to date. Beginning in Meliandou in southern Guinea in December 2013, it spread to adjacent Liberia and Sierra Leone, affecting the cities of Conakry and Monrovia, with minor outbreaks in Mali and Nigeria. Cases reached a peak in October 2014 and the epidemic was under control by late 2015, although occasional cases continued to occur into April 2016. Ring vaccination with the then-experimental vaccine rVSV-ZEBOV was trialled in Guinea.

More than 28,000 suspected cases were reported with more than 11,000 deaths; the case fatality rate was around 40% overall and around 58% in hospitalised patients. Early in the epidemic nearly 10% of the dead were healthcare workers. The outbreak left about 17,000 survivors, many of whom reported long-lasting post-recovery symptoms. Extreme poverty, dysfunctional healthcare systems, distrust of government after years of armed conflict, local burial customs of washing the body, the unprecedented spread of Ebola to densely populated cities, and the delay in response of several months all contributed to the failure to control the epidemic.

Selected quotation

—Peter Simmonds

Selected virus

Cryo-electron microscopy image of Semliki Forest virus, an alphavirus

Alphaviruses are a genus of RNA viruses in the Togaviridae family. The spherical enveloped virion is 70 nm in diameter, with a nucleocapsid of 40 nm. It has a single-stranded, positive-sense RNA genome of 11–12 kb. The genus contains more than thirty species, which infect humans, horses, rodents and other mammals, as well as fish, birds, other vertebrates and invertebrates. Alphaviruses are generally transmitted by insect vectors, predominantly mosquitoes, and are an example of arboviruses (arthropod-borne viruses).

The first alphavirus to be discovered was western equine encephalitis virus, by Karl Friedrich Meyer in 1930, in horses with fatal encephalitis in San Joaquin Valley, California, USA. Some members of the genus cause significant disease in humans, including the chikungunya, o'nyong'nyong, Ross River, Sindbis, Barmah Forest and Semliki Forest (pictured) viruses and the eastern, western and Venezuelan equine encephalitis viruses. Arthritis, encephalitis, rashes and fever are the most frequently observed symptoms. Large mammals such as humans usually form dead-end hosts for the viruses, although Venezuelan equine encephalitis virus is mainly amplified in the horse. No human vaccine or antiviral drug has been licensed. Prevention is predominantly by control of the insect vector.

Did you know?

Harald zur Hausen, photographed by Armin Kübelbeck
Harald zur Hausen, photographed by Armin Kübelbeck

Selected biography

Egyptian pharaoh Siptah might be the earliest person whose name is known to have survived polio

Many well-known people have survived the paralytic disease polio. The earliest identified case might be Siptah (pictured), Egyptian pharaoh 1197–1191 BC, whose mummified remains have a deformed leg possibly from polio. Claudius, Roman emperor 41–54 AD, walked with a limp after a childhood disease that historians have hypothesised might have been polio. Novelist Sir Walter Scott suffered paralysis in one leg after a teething fever in 1773, which left him lame; his detailed account of his disease has allowed a retrospective diagnosis of polio to be made with confidence.

For many of those who survived it, paralytic polio was a life-changing experience. The disease can lead to permanent physical disability; Itzhak Perlman, for example, plays the violin seated. Others recover completely, with some going on to excel in sports; Ray Ewry became world's foremost standing jumper after childhood polio. Some survivors, including singer Ian Dury and actress Mia Farrow, have campaigned for polio eradication or for disability rights.

In this month

Electron micrograph of SARS coronaviruses

7 November 1991: Magic Johnson announced his retirement from basketball because of his infection with HIV

14 November 1957: Kuru, the first human prion disease, described by Daniel Gajdusek and Vincent Zigas

16 November 2002: The first case of severe acute respiratory syndrome (virus pictured) recorded in Guangdong, China

17 November 1995: Lamivudine approved for treatment of HIV

22 November 2013: Simeprevir approved for treatment of chronic hepatitis C virus infection

23 November 1978: Structure of tomato bushy stunt virus solved by Stephen Harrison and colleagues, the first atomic-level structure of a virus

24 November 2007: Outbreak of new Ebola species, Bundibugyo virus

26 November 1898: Martinus Beijerinck coined the term contagium vivum fluidum to describe the agent causing tobacco mosaic disease

Selected intervention

Ball-and-stick model of aciclovir

Aciclovir (also acyclovir and sold as Zovirax) is a nucleoside analogue that mimics the nucleoside guanosine. It is active against most viruses in the herpesvirus family, and is mainly used to treat herpes simplex virus infections, chickenpox and shingles. After phosphorylation by viral thymidine kinase and cellular enzymes, the drug inhibits the viral DNA polymerase. Extremely selective and low in cytotoxicity, it was seen as the start of a new era in antiviral therapy. Aciclovir was discovered by Howard Schaeffer and colleagues, and developed by Schaeffer and Gertrude Elion, who was awarded the 1988 Nobel Prize in Medicine in part for its development. Nucleosides isolated from a Caribbean sponge, Cryptotethya crypta, formed the basis for its synthesis. Aciclovir differs from earlier nucleoside analogues in containing only a partial nucleoside structure: the sugar ring is replaced with an open chain. Resistance to the drug is rare in people with a normal immune system.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

Medicine • Microbiology • Molecular & Cellular Biology • Veterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject:

  • Commons
    Free media repository
  • Wikibooks
    Free textbooks and manuals
  • Wikidata
    Free knowledge base
  • Wikiquote
    Collection of quotations
  • Wikisource
    Free-content library
  • Wikispecies
    Directory of species
  • Wikiversity
    Free learning tools
  • Wiktionary
    Dictionary and thesaurus